109 related articles for article (PubMed ID: 25999205)
1. In silico evaluation of human small heat shock protein HSP27: homology modeling, mutation analyses and docking studies.
Fossa P; Cichero E
Bioorg Med Chem; 2015 Jul; 23(13):3215-20. PubMed ID: 25999205
[TBL] [Abstract][Full Text] [Related]
2. Overcoming HSP27-mediated resistance by altered dimerization of HSP27 using small molecules.
Kim JH; Jung YJ; Choi B; Lee NL; Lee HJ; Kwak SY; Kwon Y; Na Y; Lee YS
Oncotarget; 2016 Aug; 7(33):53178-53190. PubMed ID: 27449291
[TBL] [Abstract][Full Text] [Related]
3. Structure and properties of G84R and L99M mutants of human small heat shock protein HspB1 correlating with motor neuropathy.
Nefedova VV; Sudnitsyna MV; Strelkov SV; Gusev NB
Arch Biochem Biophys; 2013 Oct; 538(1):16-24. PubMed ID: 23948568
[TBL] [Abstract][Full Text] [Related]
4. Physico-chemical properties of R140G and K141Q mutants of human small heat shock protein HspB1 associated with hereditary peripheral neuropathies.
Nefedova VV; Datskevich PN; Sudnitsyna MV; Strelkov SV; Gusev NB
Biochimie; 2013 Aug; 95(8):1582-92. PubMed ID: 23643870
[TBL] [Abstract][Full Text] [Related]
5. New HSP27 inhibitors efficiently suppress drug resistance development in cancer cells.
Heinrich JC; Donakonda S; Haupt VJ; Lennig P; Zhang Y; Schroeder M
Oncotarget; 2016 Oct; 7(42):68156-68169. PubMed ID: 27626687
[TBL] [Abstract][Full Text] [Related]
6. Attempt to optimize some properties of fluorescent chimeras of human small heat shock protein HspB1 by modifying linker length and nature.
Datskevich PN; Muranova LK; Gusev NB
Biochemistry (Mosc); 2015 Jan; 80(1):67-73. PubMed ID: 25754041
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Mutants of Human Small Heat Shock Protein HspB1 Carrying Replacements in the N-Terminal Domain and Associated with Hereditary Motor Neuron Diseases.
Muranova LK; Weeks SD; Strelkov SV; Gusev NB
PLoS One; 2015; 10(5):e0126248. PubMed ID: 25965061
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological effect of chrom-4-one derivatives as functional inhibitors of heat shock protein 27.
Hwang SY; Kwak SY; Kwon Y; Lee YS; Na Y
Eur J Med Chem; 2017 Oct; 139():892-900. PubMed ID: 28869891
[TBL] [Abstract][Full Text] [Related]
9. Genetic variant in the HSPB1 promoter region impairs the HSP27 stress response.
Dierick I; Irobi J; Janssens S; Theuns J; Lemmens R; Jacobs A; Corsmit E; Hersmus N; Van Den Bosch L; Robberecht W; De Jonghe P; Van Broeckhoven C; Timmerman V
Hum Mutat; 2007 Aug; 28(8):830. PubMed ID: 17623484
[TBL] [Abstract][Full Text] [Related]
10. Structural and functional specificity of small heat shock protein HspB1 and HspB4, two cellular partners of HspB5: role of the in vitro hetero-complex formation in chaperone activity.
Skouri-Panet F; Michiel M; Férard C; Duprat E; Finet S
Biochimie; 2012 Apr; 94(4):975-84. PubMed ID: 22210387
[TBL] [Abstract][Full Text] [Related]
11. HspB1 dynamic phospho-oligomeric structure dependent interactome as cancer therapeutic target.
Arrigo AP; Gibert B
Curr Mol Med; 2012 Nov; 12(9):1151-63. PubMed ID: 22804238
[TBL] [Abstract][Full Text] [Related]
12. Hsp27 as a therapeutic target in cancers.
Acunzo J; Andrieu C; Baylot V; So A; Rocchi P
Curr Drug Targets; 2014 Apr; 15(4):423-31. PubMed ID: 24138636
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of heat shock protein 27 (HspB1) tumorigenic functions by peptide aptamers.
Gibert B; Hadchity E; Czekalla A; Aloy MT; Colas P; Rodriguez-Lafrasse C; Arrigo AP; Diaz-Latoud C
Oncogene; 2011 Aug; 30(34):3672-81. PubMed ID: 21423207
[TBL] [Abstract][Full Text] [Related]
14. Structure-based grafting and identification of kinase-inhibitors to target mTOR signaling pathway as potential therapeutics for glioblastoma.
Cui YH; Chen J; Xu T; Tian HL
Comput Biol Chem; 2015 Feb; 54():57-65. PubMed ID: 25625417
[TBL] [Abstract][Full Text] [Related]
15. Identification of a class of novel tubulin inhibitors.
Yi X; Zhong B; Smith KM; Geldenhuys WJ; Feng Y; Pink JJ; Dowlati A; Xu Y; Zhou A; Su B
J Med Chem; 2012 Apr; 55(7):3425-35. PubMed ID: 22435708
[TBL] [Abstract][Full Text] [Related]
16. Small-Molecule HSP27 Inhibitor Abolishes Androgen Receptors in Glioblastoma.
Li Y; Orahoske CM; Geldenhuys WJ; Bhattarai A; Sabbagh A; Bobba V; Salem FM; Zhang W; Shukla GC; Lathia JD; Wang B; Su B
J Med Chem; 2021 Feb; 64(3):1570-1583. PubMed ID: 33523674
[TBL] [Abstract][Full Text] [Related]
17. Quantification of HSP27 and HSP70 molecular chaperone activities.
Gobbo J; Gaucher-Di-Stasio C; Weidmann S; Guzzo J; Garrido C
Methods Mol Biol; 2011; 787():137-43. PubMed ID: 21898233
[TBL] [Abstract][Full Text] [Related]
18. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
Islam MA; Pillay TS
J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
[TBL] [Abstract][Full Text] [Related]
19. Phosphomimics destabilize Hsp27 oligomeric assemblies and enhance chaperone activity.
Jovcevski B; Kelly MA; Rote AP; Berg T; Gastall HY; Benesch JL; Aquilina JA; Ecroyd H
Chem Biol; 2015 Feb; 22(2):186-95. PubMed ID: 25699602
[TBL] [Abstract][Full Text] [Related]
20. RP101 (brivudine) binds to heat shock protein HSP27 (HSPB1) and enhances survival in animals and pancreatic cancer patients.
Heinrich JC; Tuukkanen A; Schroeder M; Fahrig T; Fahrig R
J Cancer Res Clin Oncol; 2011 Sep; 137(9):1349-61. PubMed ID: 21833720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
